FORM SC 13D

Company

NRX Pharmaceuticals, Inc.

Filed

December 22, 2017

Accession Number

0001654954-17-011843

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →